The official Drugs@FDA dataset lists original submission 1 for NDA 021060 with status AP dated 2004-12-28, and names ziconotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 021731 with status AP dated 2004-12-14, and names leuprolide acetate among the application record's active ingredients.
The Federal Register published notice 04-24378, attributed to FDA and its parent HHS department, on 2004-11-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GANIRELIX ACETATE INJECTION (Formerly ANTAGON),” and PeptideScanner's exact reviewed identity mapping connects the document to Ganirelix.
The official Drugs@FDA dataset lists original submission 1 for NDA 021732 with status AP dated 2004-10-12, and names histrelin acetate among the application record's active ingredients.
The Federal Register published notice 04-15570, attributed to FDA and its parent HHS department, on 2004-07-09. Its official title is “Notice of Approval of Abbreviated New Animal Drug Application; Oxytocin Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The official Drugs@FDA dataset lists original submission 1 for NDA 021256 with status AP dated 2004-04-09, and names secretin synthetic human among the application record's active ingredients.